Disparities in Cancer-Related Mortality and Long-Term Survival in Adolescent and Young Adults with Hodgkin Lymphoma: A Population-Level Analysis across the United States

Conclusion: In AYAs diagnosed with HL between 2000 and 2015, NHB patients had worse survival compared with NHW and API patients. The higher probability of survival in NHW patients was accompanied by a consistently higher proportion of non-cancer related death in this cohort both 10- years and 15-years after diagnosis. Studies are needed to evaluate risk factors for both short- and long-term mortality in AYAs, and to examine how these risks differ across racial/ethnic groups. Findings also suggest that despite increasing use of response-adapted therapy over the past two decades, all AYAs with HL remain at risk of death in the decades following therapy, further highlighting the need for long-term follow-up of this at-risk patient population.Figure.DisclosuresMuffly: Adaptive Biotechnologies: Research Funding; Shire Pharmaceuticals: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Kahn, J. M., Keegan, T. H. M., Alvarez, E., Muffly, L. S., Parsons, H., Winestone, L. E., Bleyer, A. Tags: 904. Outcomes Research-Malignant Conditions: Poster III Source Type: research